Kissei Pharmaceutical Co Ltd
TSE:4547
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 035
4 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Kissei Pharmaceutical Co Ltd
Kissei Pharmaceutical Co Ltd
Net Issuance of Common Stock
Kissei Pharmaceutical Co Ltd
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kissei Pharmaceutical Co Ltd
TSE:4547
|
Net Issuance of Common Stock
-¥5.1B
|
CAGR 3-Years
-57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-119%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Issuance of Common Stock
-¥1.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
20%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Issuance of Common Stock
-¥120.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-349%
|
CAGR 10-Years
-128%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Issuance of Common Stock
-¥20B
|
CAGR 3-Years
-2 616%
|
CAGR 5-Years
-625%
|
CAGR 10-Years
N/A
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Issuance of Common Stock
¥212m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-15%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Net Issuance of Common Stock
-¥7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
35%
|
CAGR 10-Years
19%
|
|
Kissei Pharmaceutical Co Ltd
Glance View
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. The company is headquartered in Matsumoto-Shi, Nagano-Ken and currently employs 1,863 full-time employees. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The firm is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. The company is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
See Also
What is Kissei Pharmaceutical Co Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
-5.1B
JPY
Based on the financial report for Sep 30, 2024, Kissei Pharmaceutical Co Ltd's Net Issuance of Common Stock amounts to -5.1B JPY.
What is Kissei Pharmaceutical Co Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-119%
Over the last year, the Net Issuance of Common Stock growth was -432%. The average annual Net Issuance of Common Stock growth rates for Kissei Pharmaceutical Co Ltd have been -57% over the past three years , and -119% over the past ten years .
You don't have any saved screeners yet
